Hepatitis C News and Research

Latest Hepatitis C News and Research

Focusing HIV treatment helps control concurrent hepatitis B infection

Prolonged use of highly active antiretroviral therapy (HAART) to treat people infected with both HIV and hepatitis B (HBV) helps to better control the hepatitis B infection and could delay or prevent liver complications, according to a new study by researchers at Wake Forest University School of Medicine.

15 Jul 2009

Kenya seeks support from PEPFAR to expand blood transfusion centers

Kenya's Medical Services Permanent Secretary James Ole Kiyiapi announced Thursday that the government is in negotiations with PEPFAR for support in building additional blood transfusion centers in the country, Capital News reports.

29 Jun 2009

New media-led effort responds to AIDS crisis in black America

Today, leading U.S. media companies announced a new coordinated national campaign to mobilize Black Americans in response to AIDS and promote specific calls-to-action to prevent and reduce the further spread of HIV. Greater Than AIDS - a multi-faceted campaign presented under a common brand that includes targeted public service ads (PSAs) as well as integrated messages in news, entertainment and community content - seeks to strengthen a sense of community among Black Americans in response to HIV/AIDS.

25 Jun 2009

Transplant drug Rapamycin stimulates immune memory

Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered.

22 Jun 2009

Trial of new ‘combo’ treatment for hepatitis C

In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment.

17 Jun 2009

Research supports world blood donor day message on blood safety

Other countries could learn from the mistakes made in UK blood policy concludes research awarded by the Economic and Social Research Council's Michael Young Prize.

13 Jun 2009

Study shows promise for new cancer-stopping therapy

Researchers at Nationwide Children's Hospital and Johns Hopkins University have discovered that delivering a small molecule that is highly expressed in normal tissues but lost in diseased cells can result in tumor suppression.

12 Jun 2009

HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

5 Jun 2009

Johnson & Johnson's research reflecting new Washington policies

Health care supplier Johnson & Johnson will focus on new treatments and improved tests for cancer and other diseases for which company perceives unmet needs, like diabetes, hepatitis C, and HIV, as well as using new, Washington-supported research techniques to gauge their effectiveness, researchers and executives said at a briefing with analysts, BusinessWeek reports.

5 Jun 2009

Blood pressure drug reverses liver damage

British scientists have discovered that blood-pressure drugs can reverse the effects of early-stage liver failure in some patients.

1 Jun 2009

MicroRNAs grease the cell's circadian clockwork

Most of our cells possess an internal clock, a group of genes displaying a cyclic expression pattern that reaches a peak once a day. A large number of circadian genes are expressed by organs such as the liver, whose activity needs to be precisely regulated over the course of the day.

31 May 2009

Blood-pressure medicine shown to reverse the effects of early-stage liver failure

Newcastle University researchers analysed a small clinical trial of losartan, a drug normally prescribed for hypertension, on 14 patients in Spain, who had Hepatitis C.

31 May 2009

Thai HIV/AIDS advocates urge increased treatment access for IDUs

The Thai AIDS Treatment Action Group recently called on the country to launch a comprehensive harm reduction program for injection drug users in an effort to help curb the spread of HIV, Thailand's The Nation reports.

31 May 2009

'Complacency,' 'stigma' hindering efforts to reduce HIV/AIDS in black communities, opinion piece says

"Nearly 30 years after the discovery of HIV and AIDS, the epidemic is still ravaging black neighborhoods in Baltimore and across the nation," Kevin Fenton -- director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention -- writes in a Baltimore Sun opinion piece.

28 May 2009

Hospital refuses admission to young adults with thalassemia and sickle cell disease

Young adults with thalassemia and sickle cell diease have been trying for up to 10 years to gain admission to the only adult hospital program in central and southwestern Toronto specialized to treat their blood disorders. Since 1999, the Toronto General Hospital (TGH) has restricted the inherited blood disorders program to 99 patients requiring blood transfusions. As a result, about 150 young adults with complex disorders receive blood transfusions at the Hospital for Sick Children but no adult services.

25 May 2009

Genentech and Biogen Idec submit applications to FDA for Rituxan in chronic lymphocytic leukemia

Genentech, Inc. and Biogen Idec today announced that the companies submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Rituxan (rituximab) plus standard chemotherapy for people with previously untreated or treated chronic lymphocytic leukemia (CLL).

20 May 2009

'Swift action driven by courage needed' to remove ban on federal funding for needle-exchange programs, letter to editor says

"The Obama administration's budget dealt a serious blow to those who support syringe exchange programs to prevent the transmission of HIV, hepatitis C and other infectious diseases," Paola Barahona, senior global health policy analyst for Physicians for Human Rights and founding executive director of Prevention Works!, writes in a Washington Post letter to the editor.

19 May 2009

Hepatitis C News and Research

Latest Hepatitis C News and Research

Focusing HIV treatment helps control concurrent hepatitis B infection

Kenya seeks support from PEPFAR to expand blood transfusion centers

New media-led effort responds to AIDS crisis in black America

Transplant drug Rapamycin stimulates immune memory

Trial of new ‘combo’ treatment for hepatitis C

Research supports world blood donor day message on blood safety

Study shows promise for new cancer-stopping therapy

HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

Johnson & Johnson's research reflecting new Washington policies

Blood pressure drug reverses liver damage

MicroRNAs grease the cell's circadian clockwork

Blood-pressure medicine shown to reverse the effects of early-stage liver failure

Thai HIV/AIDS advocates urge increased treatment access for IDUs

'Complacency,' 'stigma' hindering efforts to reduce HIV/AIDS in black communities, opinion piece says

Hospital refuses admission to young adults with thalassemia and sickle cell disease

Genentech and Biogen Idec submit applications to FDA for Rituxan in chronic lymphocytic leukemia

'Swift action driven by courage needed' to remove ban on federal funding for needle-exchange programs, letter to editor says

Denver Post examines efforts to establish needle-exchange programs in Colorado

Chronic infection clearly linked to key immunity protein

Swine flu preoccupies world health leaders

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Hepatitis C News and Research

Latest Hepatitis C News and Research

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Newsletters you may be interested in